Emerging imaging tools and procedural techniques have refined the diagnosis and treatment of pleural diseases, including pleural effusion, empyema, pneumothorax, and malignant mesothelioma. Ultrasound-guided thoracentesis, pleural manometry, and indwelling pleural catheters are transforming patient care by reducing complications and enabling ambulatory management. Thoracoscopy remains a cornerstone for diagnosing unexplained effusions and administering talc pleurodesis. Pleural diseases research now focuses on molecular profiling of pleural fluid and minimally invasive biomarkers to improve diagnostic yield. Multidisciplinary input from pulmonologists, thoracic surgeons, and radiologists ensures accurate assessment and tailored treatment plans. Enhanced guidelines and procedural training are improving safety and outcomes across both inpatient and outpatient care environments.
Title : Screening questionnaires for obstructive sleep apnea: An updated systematic review
Behzad Rahmati, Isfahan University of Medical Sciences, Iran (Islamic Republic of)
Title : Improving covid 19 candidate vaccine response through probiotics and micronutrient supplementation: Evaluating the role of TLR5
Zohre Eftekhari, Biotechnology Research Center, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Iatrogenic pneumothorax following nephrectomy: Case report
Chaimae Tahiri, National University Hospital Center of Fann, Senegal
Title : Towards the experience and view of personalized and precision pulmonology: An option for clinicians, geneticists and caregivers to realize the potential of genomics informed lung cancer care to secure the individualized human biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Opioid induced hypoventilation and sleep related hypoxemia in a patient on buprenorphine naloxone an underrecognized problem.
Anusha Devarajan, University of Vermont Medical Center, United States